Preparing Your Healthcare-AI Prototype for an Independent Clinical Review
An independent clinical review is one of the most valuable things a healthcare-AI founder can commission before launch — but only if the prototype is prepared for it. Reviewers work with what you give them: the clearer your intended use, your content sources and your known limitations, the deeper and more useful the findings.
This guide sets out how to prepare your healthcare-AI prototype for an independent clinical review, so the review finds the issues that matter instead of spending its time on avoidable basics. It is written for founders and product leads, from the perspective of a pediatrician by training who conducts these reviews.
In this article
- 1. Write a one-page product and intended-use summary
- 2. Document your clinical content sources
- 3. Prepare example transcripts or demo accounts
- 4. List your known limitations honestly
- 5. Show your escalation and safety-net design
- 6. Share your content review process
- 7. Decide who will act on the findings
- FAQ
1. Write a one-page product and intended-use summary
Before anything else, write down what the product is, who it is for, and what it is supposed to do — in one page, in plain language. Include the intended users (patients, clinicians, parents?), the clinical tasks in scope, and the tasks explicitly out of scope. This single page frames the entire review: without it, the reviewer must guess what “correct” looks like, and the findings will be correspondingly vague.
Be specific about the deployment context too. A prototype tested in a supervised clinic pilot faces different risks than one released to the public app stores. The reviewer needs to know which situation they are assessing.
2. Document your clinical content sources
List every source your product’s clinical content comes from: guidelines, drug references, internal documents, and — for AI-generated content — the models and prompts involved. Note the version or date of each source, and who is responsible for keeping them current.
This documentation serves two purposes. It lets the reviewer check accuracy against the right references, and it shows whether you have a maintainable content pipeline or a collection of copy-pasted text nobody owns. If you cannot produce this list, that is itself a finding — better to discover it now than during the review.
3. Prepare example transcripts or demo accounts
Reviewers need to see the product in action. Provide demo accounts with realistic test data, or a set of example transcripts covering typical use — plus the awkward cases: confused users, edge-case symptoms, non-native speakers. The more representative the examples, the more the review reflects real-world use.
Do not cherry-pick only the polished flows. A reviewer who sees only the happy path will ask for the rest, and the back-and-forth costs time. Include examples you are unsure about; those are precisely the ones most worth a reviewer’s attention. This mirrors what happens in the first minutes of testing — see what a medical reviewer notices during the first ten minutes of testing.
4. List your known limitations honestly
Every prototype has limitations: populations it was not tested on, languages it does not support well, clinical areas it handles poorly. Write them down and share them with the reviewer. This is not an admission of failure — it is the mark of a team that understands its product.
Honest limitations focus the review where it counts. If you already know the adolescent pathway is weak, the reviewer can spend less time confirming that and more on the areas you believed were solid. Hiding limitations, by contrast, guarantees they become findings — presented less kindly than if you had volunteered them.
5. Show your escalation and safety-net design
Document how the product handles the moments that matter most: medical emergencies, red-flag symptoms, users who are confused or distressed. Show the escalation paths, the response times, and what happens outside working hours. If these are not designed yet, say so — and expect the review to say so too.
Review the design yourself first against the ten clinical-safety checks for healthcare chatbots: defined boundaries, tested escalation, safe fallbacks, red-flag handling. Fixing the obvious issues before the review means the reviewer can spend their time on the subtle ones.
6. Share your content review process
Explain how clinical content gets into the product and who checks it: who writes it, who reviews it, what qualifications they hold, how often it is re-checked, and what happens when guidance changes. For AI-generated content, include the prompts, the guardrails and the human review steps.
A reviewer who sees a defined, resourced review process has confidence the findings will stay fixed. A reviewer who finds no process will flag it as a systemic issue — because content that was right once drifts wrong without maintenance.
7. Decide who will act on the findings
Before the review starts, decide who receives the findings, who decides what to fix, and by when. A review report that lands in an inbox with no owner changes nothing. Name the decision-maker, set aside engineering and clinical time for remediation, and agree how you will verify the fixes.
Plan a follow-up too. The most useful reviews are not one-off events but the start of a safety routine: fix, re-test, and re-review the areas that changed. Tell the reviewer you want this cadence — it changes what they write, from a verdict to a working document.
FAQ
When is the right time for an independent clinical review?
When the prototype is stable enough to represent the intended product, but early enough that findings can still change the design — typically before a public launch or a large pilot. Reviewing a prototype that changes daily wastes the review; reviewing after launch wastes the opportunity to prevent harm.
What does an independent clinical review actually cover?
Typically: intended use and positioning, content accuracy against trusted references, escalation and safety-net design, error handling and edge cases, user communication and health literacy, and the processes that keep content safe over time. The exact scope should be agreed with the reviewer in advance.
How should we share access with a reviewer?
Demo accounts with realistic test data are ideal; example transcripts work for conversational products. Avoid sharing real patient data — it is not needed for a thorough review and it creates privacy obligations for everyone involved.
What if the review finds serious problems?
That is the review working as intended. Serious findings before launch are far cheaper — in every sense — than serious findings after. A good review prioritises findings by risk and suggests practical fixes, so the team can act in order of importance.
How do we choose a reviewer?
Look for clinical credibility in your product’s domain (for paediatric products, paediatric input is essential), experience with digital-health products specifically, and independence from your team and investors. Ask how they work and what a sample report looks like before committing.
Building a healthcare-AI or pediatric digital-health product? DigitalProved provides an independent review of clinical content, patient-safety risks, escalation advice and user communication — handled entirely by email, no calls needed. Write to support@digitalproved.com to request a review.
